Genetics of HIV-1infection: chemokine receptor CCR5 polymorphism and its consequences
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
The chemokine receptor gene, CCR5, has become a central theme in studies of host genetic effects on HIV-1 pathogenesis ever since the discovery that the CCR5 molecule serves as a major cell surface co-receptor for the virus. A growing number of genetic variants within the coding and 5' regulatory region of CCR5 have been identified, several of which have functional consequences for HIV-1 pathogenesis. Here we review the CCR5 literature describing CCR5 polymorphism and the functional ramifications that several of these variants have on HIV-1 infection and progression to AIDS. The multiplicity of CCR5 genetic effects on HIV-1 disease underscores the critical importance of this gene in controlling AIDS pathogenesis and provides the logic for develop-ment of therapeutic strategies that target the interaction of HIV-1 envelope and CCR5 in HIV-1 associated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641 · cited 1×
“It seems unlikely that theCCR2-64Iallele has a direct effect on AIDS progression because: (i) CCR2 is used as a co-receptor by rare isolates of HIV-1 (5,6,56), and (ii) CCR2-64Iencodes a product that binds chemokine ligand, and mediates both calc mobilization signalling and R5 tropic HIV-1 infection as efficiently as…”
BackgroundHIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074 · cited 3×
“CCR5-∆32 does not produce a functiona protein (15), explaining the near-complete protection agai HIV-1 infection in individuals homozygous for the allele.”
BackgroundInfluentialSamson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Self-citationThe β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833 · cited 1×
“It seems unlikely that theCCR2-64Iallele has a direct effect on AIDS progression because: (i) CCR2 is used as a co-receptor by rare isolates of HIV-1 (5,6,56), and (ii) CCR2-64Iencodes a product that binds chemokine ligand, and mediates both calc mobilization signalling and R5 tropic HIV-1 infection as efficiently as…”
BackgroundGenotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., & Ho, D. D. (1993) · Science · doi:10.1126/science.8356453 · Cited by 1,249
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A., & Mackay, C. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1925 · Cited by 1,134
Variations on a Theme: Cataloging Human DNA Sequence Variation
Collins, F. S., Guyer, M. S., & Chakravarti, A. (1997) · Science · doi:10.1126/science.278.5343.1580 · Cited by 1,050
CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., et al. (1997) · Nature · doi:10.1038/385645a0 · Cited by 913
Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression
Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Kaslow, R., et al. (1997) · Science · doi:10.1126/science.277.5328.959 · Cited by 876
Self-citationA new classification for HIV-1
Berger, E. A., Doms, R. W., Fenyö, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., Sodroski, J., & Weiss, R. A. (1998) · Nature · doi:10.1038/34571 · Cited by 830
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1681 · Cited by 694
Molecular Cloning and Functional Expression of a New Human CC-Chemokine Receptor Gene
Samson, M., Labbe, O., Mollereau, C., Vassart, G., & Parmentier, M. (1996) · Biochemistry · doi:10.1021/bi952950g · Cited by 686 · cited 2×
“Genes encoding the CCR1-CCR5 molecules are clustered in the p21.3‐p24 region of chromosome 3 (13, 45 ,53).”
BackgroundChemokine receptors: Gateways to inflammation and infection
Premack, B. A., & Schall, T. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1174 · Cited by 630 · cited 2×
“It is through this mechanism that leukocytes are recruited into sites of inflammation (1, 2 ).”
BackgroundGlobal distribution of the CCR5 gene 32-basepair deletion
Martinson, J. J., Chapman, N. H., Rees, D. C., Liu, Y.-T., & Clegg, J. B. (1997) · Nature Genetics · doi:10.1038/ng0597-100 · Cited by 539
Dating the Origin of the CCR5-Δ32 AIDS-Resistance Allele by the Coalescence of Haplotypes
Stephens, J. C., Reich, D. E., Goldstein, D. B., Shin, H. D., Smith, M. W., Carrington, M., Winkler, C., Huttley, G. A., Allikmets, R., Schriml, L., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301867 · Cited by 520 · cited 2×
“The CCR5-Δ32 mutation is estimated to have occurred ~700‐2000 years ago ( 27 ,28) and since that time has increased to a frequency of 13% in some Northern European populations (27,29).”
BackgroundSelf-citationMoore, J. P., Trkola, A., & Dragic, T. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80110-0 · Cited by 495
Genetic Acceleration of AIDS Progression by a Promoter Variant of CCR5
Martin, M. P. (1998) · Science · doi:10.1126/science.282.5395.1907 · Cited by 461 · cited 6×
“The four alleles that we previously designated CCR5P1, CCR5P2, CCR5P3and CCR5P4(58) (Table 2) were observed at frequencies of 0.”
BackgroundResultInfluentialRaport, C. J., Gosling, J., Schweickart, V. L., Gray, P. W., & Charo, I. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17161 · Cited by 448 · cited 1×
“Comparison of this sequence with two cDNA clones (46,47) indicated the presence of a 1.”
BackgroundThe role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
Michael, N. L., Chang, G., Loum, L. G., Mascola, J. R., Dondero, D., Birx, D. L., & Sheppard, H. W. (1997) · Nature Medicine · doi:10.1038/nm0397-338 · Cited by 448
Zimmerman, P. A., Buckler-White, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C., Weissman, D., Cohen, O., Rubbert, A., Lam, G., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401665 · Cited by 416
Richman, D. D., & Bozzette, S. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.968 · Cited by 401
CCR5 promoter polymorphism and HIV-1 disease progression
McDermott, D. H., Zimmerman, P. A., Guignard, F., Kleeberger, C. A., Leitman, S. F., & Murphy, P. M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04158-0 · Cited by 390
Kostrikis, L. G., Huang, Y., Moore, J. P., Wolinsky, S. M., Zhang, L., Guo, Y., Deutsch, L., Phair, J., U. Neumann, A., & D. Ho, D. (1998) · Nature Medicine · doi:10.1038/nm0398-350 · Cited by 388 · cited 4×
“The variant CCR2-64I in the first transmembrane region ofCCR2has been shown to be associated with relative slow progression to AIDS (54,55) and this protection genetically independent of that conferred by CCR5-∆32.”
BackgroundInfluentialMechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32
Benkirane, M., Jin, D.-Y., Chun, R. F., Koup, R. A., & Jeang, K.-T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30603 · Cited by 377
Wu, L., LaRosa, G., Kassam, N., Gordon, C. J., Heath, H., Ruffing, N., Chen, H., Humblias, J., Samson, M., Parmentier, M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1373 · Cited by 357
HIV-1 infection in an individual homozygous for the CCR5 deletion allele
Biti, R., Ffrench, R., Young, J., Bennetts, B., Stewart, G., & Liang, T. (1997) · Nature Medicine · doi:10.1038/nm0397-252 · Cited by 352
Mummidi, S., Ahuja, S. S., Gonalez, E., Anderson, S. A., Santiago, E. N., Stephan, K. T., Craig, F. E., O'Connell, P., Tryon, V., Clark, R. A., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-786 · Cited by 339 · cited 3×
“, A number of additional variants in the 5 ′-UTR of CCR5have been identified (50,58,59) and seven of these distinguish four common promoter region alleles identified in Caucasian and African American samples (positions – 2733, –2554, –2459, –2135, –2132, –2086and –1835in Fig.”
BackgroundChemokine receptors: Structure, function and role in microbial pathogenesis
Murphy, P. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00009-3 · Cited by 320 · cited 1×
“It is through this mechanism that leukocytes are recruited into sites of inflammation (1,2).”
BackgroundHIV entry and tropism: the chemokine receptor connection.
Berger, E. A. (1997) · PubMed · Cited by 313
Chemokine Receptors: Keys to AIDS Pathogenesis?
Littman, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81429-4 · Cited by 300
Combadiere, C., Ahuja, S. K., Lee Tiffany, H., & Murphy, P. M. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.147 · Cited by 292
Libert, F. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.399 · Cited by 292 · cited 1×
“The CCR5-Δ32 mutation is estimated to have occurred ~700‐2000 years ago (27, 28 ) and since that time has increased to a frequency of 13% in some Northern European populations (27,29).”
BackgroundHIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
Quillent, C., Oberlin, E., Braun, J., Rousset, D., Gonzalez-Canali, G., Métais, P., Montagnier, L., Virelizier, J.-L., Arenzana-Seisdedos, F., & Beretta, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09185-x · Cited by 271
Association between CCR5 Genotype and the Clinical Course of HIV-1 Infection
de Roda Husman, A.-M., Koot, M., Cornelissen, M., Keet, I. P. M., Brouwer, M., Broersen, S. M., Bakker, M., Roos, M. T. L., Prins, M., de Wolf, F., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00004 · Cited by 267
HIV-1 infection in a man homozygous for CCR5▵32
O'Brien, T. R., Winkler, C., Dean, M., Nelson, J. A., Carrington, M., Michael, N. L., & White, G. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)24017-1 · Cited by 262
Self-citationThe role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression
Michael, N. L., Louie, L. G., Rohrbaugh, A. L., Schultz, K. A., Dayhoff, D. E., Wang, C. E., & Sheppard, H. W. (1997) · Nature Medicine · doi:10.1038/nm1097-1160 · Cited by 251 · cited 1×
“Individuals with the genotypeCCR5-+/∆32 express lower levels of CCR5 correlating with relatively low viral loads (44) and slow progression to AIDS (14,20–22).”
BackgroundHIV-1 infection in an individual homozygous for CCR5▵32
Theodorou, L., Meyer, L., Magierowska, M., Katlama, C., & Rouzioux, C. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62411-7 · Cited by 240
Lee, B., Doranz, B. J., Rana, S., Yi, Y., Mellado, M., Rodríguez-Frade, J. M., Martínez‐A, C., O’Brien, S. J., Dean, M. C., Collman, R. G., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7450-7458.1998 · Cited by 176
The Human CC Chemokine Receptor 5 (CCR5) Gene
Mummidi, S., Ahuja, S. S., McDaniel, B. L., & Ahuja, S. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30662 · Cited by 165 · cited 5×
“There are two distinct promoters of CCR5, one of which lies upstream of exon 1 (Pu), and another that lies downstream in the regio between intron 1 and exon 2 (P d) (50).”
BackgroundMethodInfluentialNovel Alleles of the Chemokine-Receptor Gene CCR5
Carrington, M. N., Kissner, T. L., Gerrard, B., Ivanov, S. V., O’Brien, S. J., & Dean, M. C. (1997) · The American Journal of Human Genetics · doi:10.1086/301645 · Cited by 161 · cited 2×
“Each of six variants (I12T, C20S, I42F, L55Q, A73V an C101X) in cohorts studied were identified in individuals carryin theCCR5-∆32allele on the opposite haplotype (31,33).”
BackgroundSelf-citationBordeaux, J. D. (2003) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsg004 · Cited by 123
Host Genes and HIV: The Role of the Chemokine Receptor Gene CCR5 and Its Allele (∆32 CCR5)
McNicholl, J. M., Smith, D. K., Qari, S. H., & Hodge, T. W. (1997) · Emerging infectious diseases · doi:10.3201/eid0303.970302 · Cited by 120
The extent of genetic variation in the CCR5 gene
Ansari-Lari, M. A., Liu, X.-M., Metzker, M. L., Rut, A. R., & Gibbs, R. A. (1997) · Nature Genetics · doi:10.1038/ng0797-221 · Cited by 118 · cited 2×
“bFound at 3–5% in Asian populations (30).”
BackgroundChemokines and HIV-1 second receptors: The therapeutic connection
Cairns, J. S., & D’Souza, M. P. (1998) · Nature Medicine · doi:10.1038/nm0598-563 · Cited by 118
The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.
Frade, J. M., Llorente, M., Mellado, M., Alcamí, J., Gutiérrez-Ramos, J. C., Zaballos, A., Real, G., & Martínez-A, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119558 · Cited by 111 · cited 1×
“The variant CCR2-64I in the first transmembrane region of CCR2 has been shown to be associated with relatively slow progression to AIDS (54,55) and this protection is genetically independent of that conferred by CCR5-Δ32 .I t seems unlikely that the CCR2-64I allele has a direct effect on AIDS progression because: (i)…”
BackgroundRabkin, C. S., Yang, Q., Goedert, J. J., Nguyen, G. T., Mitsuya, H., & Sei, S. (1999) · Blood · doi:10.1182/blood.v93.6.1838.406k39_1838_1842 · Cited by 106
Samson, M., Soularue, P., Vassart, G., & Parmentier, M. (1996) · Genomics · doi:10.1006/geno.1996.0498 · Cited by 104
Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation.
Dean, M. C., Jacobson, L. P., McFarlane, G., Margolick, J. B., Jenkins, F. J., Howard, O. M. Z., Dong, H., Goedert, J. J., Buchbinder, S., Gomperts, E. D., et al. (1999) · PubMed · Cited by 96
Self-citationBONINI, J. A., MARTIN, S. K., DRALYUK, F., ROE, M. W., PHILIPSON, L. H., & STEINER, D. F. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.1249 · Cited by 94
Howard, O. M. Z., Shirakawa, A., Turpin, J. A., Maynard, A. T., Tobin, G. J., Carrington, M. N., Oppenheim, J. J., & Dean, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16228 · Cited by 72 · cited 7×
“Each of six variants (I12T, C20S, I42F, L55Q, A73V an C101X) in cohorts studied were identified in individuals carryin theCCR5-∆32allele on the opposite haplotype (31,33).”
BackgroundInfluentialSelf-citationFunctional Analysis of the Proximal CCR5 Promoter
LIU, R., ZHAO, X., GURNEY, T. A., & LANDAU, N. R. (1998) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1998.14.1509 · Cited by 63 · cited 1×
“Sequence motifs similar t consensus sequences for a variety of transcription factors h been identified in the P d promoter region and mutational analysi of several such sequences indicated their importance transcription ofCCR5(51).”
BackgroundGene Organization and Promoter Function for CC Chemokine Receptor 5 (CCR5)
Guignard, F., Combadière, C., Tiffany, H. L., & Murphy, P. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.985 · Cited by 56 · cited 4×
“Characterization of the CCR5promoter The original partial length genomic clone ofCCR5showed that it specified a single open reading frame (ORF) (45).”
BackgroundInfluentialCCR5 Promoter Alleles and Specific DNA Binding Factors
Bream, J. H., Young, H. A., Rice, N., Martin, M. P., Smith, M. W., Carrington, M., & O'Brien, S. J. (1999) · Science · doi:10.1126/science.284.5412.223a · Cited by 39
Self-citation
Cited by
Human susceptibility and resistance to Norwalk virus infection
Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J., & Baric, R. (2003) · Nature Medicine · doi:10.1038/nm860 · Cited by 1,119
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
Simon, V., Ho, D. D., & Abdool Karim, Q. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69157-5 · Cited by 730
Macrophage inflammatory protein-1
Menten, P., Wuyts, A., & Van Damme, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00045-x · Cited by 706
Moore, J. P., Kitchen, S. G., Pugach, P., & Zack, J. A. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322749567 · Cited by 494
Patterns of Human Genetic Diversity: Implications for Human Evolutionary History and Disease
Tishkoff, S. A., & Verrelli, B. C. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110226 · Cited by 388
Metadata
- Authors
- Carrington, M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-09-01
- Volume
- 8
- Issue
- 10
- Pages
- 1939-1945
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2156904056
- Cited by
- 232
- References
- 58
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.